NCT02410044View on ClinicalTrials.gov

Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

December 23, 2014

Primary Completion Date

August 16, 2019

Study Completion Date

August 16, 2020

Conditions
Breast CancerProstate CancerBone Metastases
Trial Locations (1)

Unknown

Multiple sites all over Germany, Multiple Locations

All Listed Sponsors
lead

iOMEDICO AG

INDUSTRY

NCT02410044 - Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer | Biotech Hunter | Biotech Hunter